Login to Your Account



To Tweet or Not to Tweet?

'New Territory': Biotechs Await FDA Rules on Social Media

By Arlene Weintraub


Monday, January 17, 2011
To casual observers, Genentech Inc.'s Jan. 5 tweet might have seemed oddly mysterious. "FDA grants Genentech medicine supplemental approval in rheumatoid arthritis," read the tweet. But which medicine was it? And what exactly did the FDA say?

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription